Evaluation of Vaccinia Viral Lysates as Therapeutic Vaccines in the Treatment of Melanomaa
- 1 August 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 690 (1) , 167-177
- https://doi.org/10.1111/j.1749-6632.1993.tb44006.x
Abstract
Click on the article title to read more.Keywords
This publication has 16 references indexed in Scilit:
- Inflammatory cell infiltrates in human melanoma at different stages of tumor progressionInternational Journal of Cancer, 1988
- Active Immunotherapy of Human Melanoma Exploiting the Immunopotentiating Effects of CyclophosphamideCancer Investigation, 1988
- Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanomaCancer Immunology, Immunotherapy, 1987
- Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effectsInternational Journal of Cancer, 1986
- Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanomaPathology, 1985
- CURRENT STATUS AND FUTURE PROSPECTS FOR ADJUVANT THERAPY OF MELANOMAAnz Journal of Surgery, 1984
- Randomized versus historical controls for clinical trialsThe American Journal of Medicine, 1982
- Specific immunotherapy with vaccinia oncolysatesCancer Immunology, Immunotherapy, 1981
- Virus-modified homologus tumor-cell extract in the treatment of vulvar carcinomaCancer Immunology, Immunotherapy, 1980
- Non-Randomized Controls in Cancer Clinical TrialsNew England Journal of Medicine, 1974